Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer

被引：0
|
作者：
A. Finelli
M. Komisarenko
L. J. Martin
N. Timilshina
K. Jain
J. Morris
A. Zlotta
G. Kulkarni
N. Perlis
T. van der Kwast
A. Evans
S. Ghai
N. Fleshner
S. M. H. Alibhai
R. J. Hamilton
机构：
[1] Princess Margaret Cancer Centre,Division of Urology, Department of Surgical Oncology
[2] University of Toronto,Division of Urology, Department of Surgical Oncology
[3] Mount Sinai Hospital and University Health Network,Department of Medicine, Institute of Health Policy, Management, and Evaluation
[4] University of Toronto,undefined
[5] University Health Network,undefined
[6] University of Toronto,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：69 / 76
页数：7
相关论文
共 50 条
  • [1] Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer
    Finelli, A.
    Komisarenko, M.
    Martin, L. J.
    Timilshina, N.
    Jain, K.
    Morris, J.
    Zlotta, A.
    Kulkarni, G.
    Perlis, N.
    van der Kwast, T.
    Evans, A.
    Ghai, S.
    Fleshner, N.
    Alibhai, S. M. H.
    Hamilton, R. J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (01) : 69 - 76
  • [2] 5-ALPHA-REDUCTASE INHIBITORS IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Dai, Charles
    Ganesan, Vishnu
    Zabell, Joseph
    Nyame, Yaw
    Hettel, Daniel
    Almassi, Nima
    Greene, Daniel
    Haywood, Samuel
    Reichard, Chad
    Zampini, Anna
    Crane, Alice
    Arora, Hans
    El-Shafei, Ahmed
    Stein, Robert
    Fareed, Khaled
    Gong, Michael
    Jones, J. Stephen
    Stephenson, Andrew
    Klein, Eric
    JOURNAL OF UROLOGY, 2016, 195 (04): : E229 - E229
  • [3] Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer
    Chiang, Andrew S.
    Loblaw, D. Andrew
    Jethava, Vibhuti
    Sethukavalan, Perakaa
    Zhang, Liying
    Vesprini, Danny
    Mamedov, Alexandre
    Nam, Robert
    Klotz, Laurence
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (11-12): : 450 - 453
  • [4] The use of 5-alpha-reductase inhibitors for the prevention of prostate cancer
    Yu, Eun-mi
    El-Ayass, Walid
    Aragon-Ching, Jeanny B.
    CANCER BIOLOGY & THERAPY, 2010, 10 (01) : 11 - 12
  • [5] The role of 5-alpha-reductase inhibitors in active surveillance
    Margel, David
    Fleshner, Neil
    CURRENT OPINION IN UROLOGY, 2012, 22 (03) : 243 - 246
  • [6] Role of 5-alpha-reductase inhibitors in active surveillance of patients with low-risk prostate cancer
    Chiang, Andrew Szehsun
    Loblaw, D. Andrew
    Jethava, Vibhuti
    Sethukavalan, Perakaa
    Zhang, Liying
    Vesprini, Danny
    Mamedov, Alexandre
    Nam, Robert
    Klotz, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [7] 5-alpha-reductase inhibitors for prostate cancer prevention
    不详
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (06) : 553 - 553
  • [8] 5α-reductase inhibitors and the risk of grade reclassification for men with long-term follow-up on active surveillance for prostate cancer.
    Finelli, Antonio
    Timilshina, Narhari
    Komisarenko, Maria
    Sowerby, Robert
    Hamilton, Robert James
    Zlotta, Alexandre
    Fleshner, Neil Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [9] Impact of 5α-Reductase Inhibitors on Men Followed by Active Surveillance for Prostate Cancer
    Finelli, Antonio
    Trottier, Greg
    Lawrentschuk, Nathan
    Sowerby, Robert
    Zlotta, Alexandre R.
    Radomski, Lenny
    Timilshina, Narhari
    Evans, Andrew
    van der Kwast, Theodorus H.
    Toi, Ants
    Jewett, Micheal A. S.
    Trachtenberg, John
    Fleshner, Neil E.
    EUROPEAN UROLOGY, 2011, 59 (04) : 509 - 514
  • [10] PROSTATE EFFECTS OF 5-ALPHA-REDUCTASE INHIBITORS
    RASMUSSON, GH
    REYNOLDS, GF
    STEINBERG, NG
    PATEL, GF
    WALTON, E
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1987, 193 : 8 - MEDI
12345